Beste aminoazido babestu batzuk disulfuro loturarako
Produktuaren xehetasuna
| NO | Produktuak | CAS zenbakia | Aplikazioa | Kalitate Adierazle Nagusia | ||||
| Garbitasuna | Isomeroa | Ezpurutasun espezifikoa | *Max1 | Hezetasuna | ||||
| 1 | Fmoc-Cys(Acm)-OH | 86060-81-3 | Disulfuro lotura | ≥99.0% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1.0% |
| 2 | Fmoc-Cys(Mmt)-OH | 177582-21-7 | Disulfuro lotura | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 3 | Fmoc-Cys(4-alilbutirato)-OH | / | Disulfuro lotura | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 4 | Mpa(Trt)-OH | 27144-18-9 | Sekuentziaren amaiera | ≥99.5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 5 | Fmoc-Thr(tBu)-OL | 189337-28-8 | Oktreotida | ≥97.0% | ≤0,3% | ≤0,5% | ≤1.0% | ≤1.0% |
| 6 | Fmoc-D-Arg(pbf)-OH | 187618-60-6 | Desmopresina | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤2.0% |
| 7 | Fmoc-Gly-Gly-OH | 35665-38-4 | Bivalirudina | ≥99.5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 8 | Fmoc-Gly-Gly-Gly-OH | 170941-79-4 | Terlipresina | ≥99.5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 9 | Fmoc-Gly-Gly-Gly-Gly-OH | / | Bivalirudina | ≥99.5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 10 | Fmoc-Gly-Asp(tBu)-OH | / | Bivalirudina | ≥99.5% | / | ≤0,15% | ≤0,2% | ≤1.0% |
| 11 | Boc-Cys(Trt)-OH | 21947-98-8 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 12 | Boc-Arg(pbf)-OH | 200124-22-7 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 13 | Boc-Ala-OH | 15761-38-3 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 14 | Boc-D-Phe-OH | 18942-49-9 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 15 | Boc-Gly-OH | 4530-20-5 | Sekuentziaren amaiera | ≥99.5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 16 | Boc-Lys(Boc)-OH.DCHA | 15098-69-8 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 17 | Boc-Ser(tBu)-OH | 7738-22-9 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 18 | Boc-Thr(tBu)-OH | 13734-40-2 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 19 | Boc-D-Ala-OH | 7764-95-6 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 20 | Boc-Met-OH | 2488-15-5 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 21 | Boc-Tyr(tBu)-OH | 47375-34-8 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 22 | Boc-D-Arg(pdf)-OH | 187618-60-6 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 23 | Boc-Asp(OtBu)-OH.DCHA | 1913/12/8 | Sekuentziaren amaiera | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 24 | Fmoc-HomoArg(pbf)-OH | 1159680-21-3 | Eptifibatida | ≥98.5% | ≤0,2% | / | ≤0,5% | ≤2.0% |
| 25 | Fmoc-Asp-OtBu | 129460-09-9 | Timalfasina | ≥99.5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1.0% |
| 26 | Fmoc-Tyr(Me)-OH | 77128-72-4 | Karbetozina | ≥98.5% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 27 | Fmoc-Orn(Boc)-OH | 109425-55-0 | Atosiban Omnipresina Daptomizina | ≥99.5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤2.0% |
| 28 | Fmoc-D-Tyr(Et)-OH | 162502-65-0 | Atosiban | ≥99.5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1.0% |
| 29 | Fmoc-Asp(OAll)-OH | 146982-24-3 | Melanotan | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 30 | Ac-Nle-OH | 15891-49-3 | Melanotan | ≥99.0% | / | ≤0,3% | ≤0,3% | ≤1.0% |
| 31 | Fmoc-Nle-OH | 77284-32-3 | Melanotan Afamelanotida | ≥99.0% | / | ≤0,3% | ≤0,3% | ≤1.0% |
| 32 | Ac-Glu(OtBu)-OH | 84192-88-1 | Argireline Azetil oktapeptido-3 | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 33 | Ac-β-Ala-OH·DCHA | / | Azetil tetrapeptido-5 | ≥99.0% | / | ≤0,3% | ≤0,3% | ≤1.0% |
| 34 | Fmoc-ß-Ala-OH | 35737-10-1 | Azetil tetrapeptido-5 | ≥99.5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 35 | Fmoc-Hyp(tBu)-OH | 122996-47-8 | Icatibant | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 36 | Fmoc-Thi-OH | 130309-35-2 | Icatibant | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 37 | Fmoc-D-Tic-OH | 130309-33-0 | Icatibant | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 38 | Fmoc-Oic-OH | 130309-37-4 | Icatibant | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 39 | Boc-Sar-OH | 13734-36-6 | Saralasin | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 40 | Fmoc-Sar-OH | 77128-70-2 | Saralasin | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 41 | Fmoc-Tyr(SO3Na)-OH.H2O | 106864-37-3 | Sinkalide | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 42 | Fmoc-D-Asp(OtBu)-OH | 112883-39-3 | Daptomizina | ≥98.5% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 43 | Ac-Ser(tBu)-OH | 77285-09-7 | Afamelanotida | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 44 | Boc-HomoCys(Trt)-OH | 201419-16-1 | Depreotida | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 45 | Fmoc-HomoCys(Trt)-OH | 167015-23-8 | Depreotida | %98,0 ≥ | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 46 | Fmoc-Dab-OH | 161420-87-7 | Sugearen pozoia | ≥99.0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
*Max1 = Gehienezko purutasun ezezaguna
Beste adierazle bat:
- Azido azetikoa: ≤0,02% (Produktu guztiak)
- Etil azetatoa: ≤0,5% (Produktu guztiak)
- Alkohola: ≤0,5% (Produktu guztiak)
- Gehienezko ezpurutasun ezezaguna: Fmoc-Trp(Boc)-OH (143824-78-6) ≤0,3%; Besteak ≤0,2%
